# CR162 Quality Review

## Findings

No release-blocking finding in the approved correction scope.

## Residual Risk

- `R-CR162-RECURRENCE-CONTROL-GAP` (medium): the current nine-document refresh is verified, but Meta Flow does not yet automatically assert that every `affected_product_docs` entry was updated when `product_baseline_refresh_required=true`. `FU-CR162-001` remains the approved recurrence-prevention candidate.

## Review Boundary

This is a static documentation review. It establishes current-baseline traceability, not independent QA and not evidence computation, runtime readiness or trading authorization.
